| Date | Form | Description | Docs | XBRL | Pages |
| 09/20/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/16/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 06/19/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 06/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 03/25/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 03/18/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
61 | |
| 09/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
27 |
| 06/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
46 |
| 03/16/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
44 |
| 11/30/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
36 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...